T. Kondo et al., ADVERSE-EFFECTS OF ZOTEPINE AND THEIR RELATIONSHIP TO SERUM CONCENTRATIONS OF THE DRUG AND PROLACTIN, Therapeutic drug monitoring, 16(2), 1994, pp. 120-124
Adverse effects of zotepine, an antipsychotic drug, and their relation
ship to serum concentrations of the drug and prolactin were investigat
ed in 28 schizophrenic in-patients. The daily dose was 100 mg during t
he first week and 200 mg during the next 3 weeks. Adverse effects were
evaluated by the UKU Side Effect Rating Scale (21 items). The mean (/-SD) total UKU score at the end of the study was 3.1 +/- 2.5, indicat
ing mild adverse effects. The scores of psychic adverse effects at 2 w
eeks and total adverse effects at 3 and 4 weeks were significantly hig
her in nonresponders than in responders (p < 0.05). Furthermore, there
was a significant inverse correlation between percent improvement in
total Brief Psychiatric Rating Scale (BPRS) scores and total UKU score
s at 4 weeks (p < 0.05). These results suggest a relationship between
poor clinical response and increased adverse effects during zotepine t
reatment. Only the scores of akathisia at 2 weeks showed a significant
ly positive correlation with serum zotepine concentrations (p < 0.05).
No correlation was found between prolactin response and neurological
adverse effects.